Clinical

BTK inhibitor implementation for MS treatment is explored.

The panelists provide insights into the decision-making process behind switching MS treatment strategies due to lacking or failed therapies.

Outcomes for patients with this form of the disease are poor and treatment options are limited.

Measurable residual disease (MRD) can predict disease progression in patients who have acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and chronic myeloid leukemia (CML).

This retrospective study showed that anti–interleukin-17 drug secukinumab yielded favorable results in a small group of patients with severe hidradenitis suppurativa (HS).

There are several reasons patients with multiple myeloma may experience the electrolyte abnormality.

Authors suggest the finding may indicate the cells play a role in hematological malignancies.

The Mayo Clinic’s Program for Rare and Undiagnosed Diseases was first implemented in 2018.

There are various immunotherapies being used in the second ling for patients with lymphomas, some of which have curative potential, explained Christopher Flowers, MD, MS, of the University of Texas MD Anderson Cancer Center.

Key opinion leaders discuss the value of real-world evidence in the management of HIV.

Assessing the quality of an HIV treatment plan is crucial to patient prognosis.

The therapy is still not widely used among older patients who have diffuse large B-cell lymphoma (DLBCL).

The treatment is the first approved by the FDA to treat the 2 most common subtypes of generalized myasthenia gravis.

In her closing thoughts, Dr Filer provides insights into the unmet needs in the treatment of RSV.

Discussion surrounding promotion of RSV vaccine awareness is further discussed.

The panel offers strategies for being proactive .

Investigators say their data show the importance of vaccination and antibiotic stewardship programs.

Dr Haumschild leads a discussion surrounding patient and provider collaboration to avoid clinical inertia in MS treatment pathways.

Frontline treatment options and the benefits of early intervention of MS are illustrated.

Gene therapy is only one exciting area of treatments in the pipeline to potentially treat inherited retinal disease, said Byron L. Lam, MD, professor of ophthalmology, University of Miami Miller School of Medicine's Bascom Palmer Eye Institute.

Latina women at risk of hereditary breast and ovarian cancer are less likely to be referred for genetic counseling and testing.

A new review outlines strategies that may help reduce the risk of severe cytokine release syndrome (CRS) for patients treated with immunotherapy.

The study was conducted to provide insight into real-world Bruton tyrosine kinase (BTK) inhibitor treatment patterns in mantle cell lymphoma, as current data are limited.

A recent review highlighted a selection of emerging therapies and advances in sickle cell disease (SCD) that focus on renal manifestations.

Researchers discovered that exercise helps to alleviate various symptoms for patients with chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis, interstitial lung disease, and lung cancer.

Researchers noted that despite the promising findings, more novel treatments are needed to overcome the disease’s resistance.

Researchers found that those with both type 2 diabetes and chronic obstructive pulmonary disease (COPD) had lower all-cause and respiratory-cause mortality survival probabilities than those without COPD.

Medical experts discuss the significance of pill burden in the HIV treatment pathway.

The role of and indication for long-acting injectables is highlighted as a treatment approach for HIV.

Experts discuss the financial needs for RSV vaccines through a payer lens.